课题基金 / 基金详情

Eosinophil and neutrophil ETosis during human filarial infection

Eosinophil and neutrophil ETosis during human filarial infection
人类丝虫感染期间的嗜酸性粒细胞和中性粒细胞 ETosis
批准号:
461670784
负责人:
Professor Dr. Marc Hübner
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Marc Hübner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Filariae can cause debilitating diseases in humans such as onchocerciasis, which can lead to severe dermatitis and blindness. However, not all onchocerciasis patients develop these clinical pictures and other filarial species often cause mild infections. Granulocytes are involved in the development of onchocerciasis-induced symptoms by triggering inflammatory responses to dying microfilariae (MF), the progeny of filariae. Our own studies with the rodent filariae Litomosoides sigmodontis show that eosinophil and neutrophil granulocytes are essential for protective immune responses in the mouse model. Here, we discovered that MF induce the release of extracellular DNA nets (ETosis) from eosinophils via Dectin-1, thereby supporting MF elimination. Interestingly, dead MF trigger a stronger ETosis response via a different signaling cascade. Based on these observations in the mouse model, we hypothesize that human MF also induce ETosis and that this is enhanced in granulocytes from onchocerciasis patients with clinical symptoms. Therefore, in the present application we would like to compare eosinophils and neutrophils from onchocerciasis patients with and without clinical manifestations as well as endemic, non-infected individuals. In particular, their ability to induce MF-induced ETosis will be investigated. In addition, we will analyze whether MF of different filarial species differ in their ability to induce ETosis. We hypothesize that filarial species that generally lead to mild infections (Mansonella, Loa) induce weaker ETosis responses than filarial species that cause clinical manifestations (Onchocerca). Furthermore, we hypothesize that dead MF induce a stronger ETosis than live MF due to the recognition of endosymbiotic Wolbachia bacteria, which induce a different signaling cascade. Analysis of granulocyte ETosis with Wolbachia-containing filariae (Onchocerca, Mansonella) and Wolbachia-free filariae (Loa) as well as live and dead MF with blocking antibodies for different pattern recognition receptors will clarify this. These experiments will be carried out with our long-term collaboration partner Prof. Wanji in Cameroon. For this purpose, a transfer of the state-of-the-art methods for the investigation of ETosis established in Bonn to Cameroon will take place. Within the framework of this project, a female postdoctoral student, two female PhD students and a master student in Cameroon and a postdoctoral student in Bonn will be supported and workshops will be given to train additional students. Prof. Wanji has access to filariasis patients and the proven expertise and infrastructure to cultivate human filariae in vitro and perform immunological studies. Thus, the aim of this application is to transfer the latest findings in filarial-induced ETosis from animal models to humans, for which Prof. Wanji's laboratory is perfectly suited.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of human filarial infections on the metabolic and immunological profile
Crosstalk of macrophages and eosinophils in helminth-mediated protection during experimental sepsis
国内基金
海外基金
Mettl3/Syk/MAPK通路调控中性粒细胞胞 外诱捕网 (neutrophil extracellular traps, NETs)的形成对脓毒症急性肺损 伤影响的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    罗舒华
  • 依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    杨程德
  • 依托单位:
IFITM1+ IL1RAP+ neutrophil通过调控巨噬细胞表型转换驱动ALPPS肝再生的机制研究
  • 批准号:
    82370624
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    吕涛
  • 依托单位:
基于Neutrophil-DCs-naive T细胞轴研究“脱敏定喘汤”调体治疗中性粒细胞型过敏性哮喘的机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    周玉美
  • 依托单位: